Pharmaceutical and biotech companies are increasingly investing in the research and development of new therapies to address the world’s growing need for earlier and more effective patient treatment. This rising demand has caused the pace of innovation in drug development, manufacture and delivery to accelerate rapidly. Additionally, the adoption of biologics in controlling diseases such as diabetes, inflammation and cancer has fuelled much of this innovation.
As an established IVD company, Randox Biosciences offers tailored diagnostic solutions to support faster, more effective and safe development of new drugs. We have a wide range of in house capabilities, ranging from the selection and patenting of novel Biomarkers; manufacture of bio reagents; production of single and multiplex IVD grade tests; quality control; provision of clinical laboratory services; regulatory expertise and worldwide distribution.